$39.92
-0.75-1.84%
Dern. MÀJ: Oct 2, 5:48 PM
$40.00
-0.67-1.65%
Sanofi (SNY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2026) a publié ses dernières prévisions le $55.79B - $55.79B pour Sanofi {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
undefined a publié undefined mises à jour de ses recommandations entre undefined et undefined. undefined
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.09 | $1.06 | $0.84 | $1.60 |
| Actual | $1.21 | $1.10 | $0.89 | $1.70 |
| Surprise | +11.4% | +3.77% | +5.95% | +6.31% |
| Revenue | ||||
| Estimate | $12.65B | $11.99B | $13.41B | $14.46B |
| Actual | $13.48B | $12.31B | $13.16B | $14.54B |
| Surprise | +6.58% | +2.64% | -1.87% | +0.54% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.72 | $1.01 | $1.14 | $1.29 |
| Revenue | ||||
| Consensus | $15.33B | $14.44B | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $1.21 | $1.09 | 11.4 % |
| Q1 | Apr 23, 2026 | $1.10 | $1.06 | 3.77 % |
| Q4 | Jan 29, 2026 | $0.89 | $0.84 | 5.95 % |
| Q3 | Oct 24, 2025 | $1.70 | $1.60 | 6.31 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $13.48B | $12.65B | 6.58 % |
| Q1 | Apr 23, 2026 | $12.31B | $11.99B | 2.64 % |
| Q4 | Jan 29, 2026 | $13.16B | $13.41B | -1.87 % |
| Q3 | Oct 24, 2025 | $14.54B | $14.46B | 0.54 % |